- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
NeuroMetrix is a medical devices business based in the US. NeuroMetrix shares (NURO) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.84 – a decrease of 1.54% over the previous week. NeuroMetrix employs 26 staff and has a trailing 12-month revenue of around $3.8 million.
Our top picks for where to buy NeuroMetrix stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy NeuroMetrix stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – NURO. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy NeuroMetrix stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
NeuroMetrix stock price (NASDAQ: NURO)
Use our graph to track the performance of NURO stocks over time.NeuroMetrix shares at a glance
Information last updated 2024-12-18.
| Latest market close | $3.84 |
|---|---|
| 52-week range | $2.66 - $4.73 |
| 50-day moving average | $4.06 |
| 200-day moving average | $3.91 |
| Wall St. target price | $50.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-4.51 |
Is it a good time to buy NeuroMetrix stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
NeuroMetrix price performance over time
Historical closes compared with the close of $3.77 from 2024-12-17
| 1 week (2024-12-12) | -3.33% |
|---|---|
| 1 month (2024-11-20) | -13.13% |
| 3 months (2024-09-19) | -1.31% |
| 6 months (2024-06-18) | 1.21% |
| 1 year (2023-12-19) | 9.28% |
|---|---|
| 2 years (2022-12-19) | -67.27% |
| 3 years (2021-12-17) | 43.44 |
| 5 years (2019-12-19) | 35.2 |
NeuroMetrix financials
| Revenue TTM | $3.8 million |
|---|---|
| Gross profit TTM | $5.8 million |
| Return on assets TTM | -28.21% |
| Return on equity TTM | -42.78% |
| Profit margin | -203.71% |
| Book value | $7.99 |
| Market Capitalization | $7.8 million |
TTM: trailing 12 months
NeuroMetrix share dividends
We're not expecting NeuroMetrix to pay a dividend over the next 12 months.
Have NeuroMetrix's shares ever split?
NeuroMetrix's shares were split on a 1:8 basis on 21 November 2023 . So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your NeuroMetrix shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for NeuroMetrix shares which in turn could have impacted NeuroMetrix's share price.
NeuroMetrix share price volatility
Over the last 12 months, NeuroMetrix's shares have ranged in value from as little as $2.66 up to $4.73. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NeuroMetrix's is 2.301. This would suggest that NeuroMetrix's shares are significantly more volatile than the average for this exchange and represent a higher risk.
NeuroMetrix overview
NeuroMetrix, Inc. , a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts. .
Frequently asked questions
What percentage of NeuroMetrix is owned by insiders or institutions?Currently 25.451% of NeuroMetrix shares are held by insiders and 3.012% by institutions. How many people work for NeuroMetrix?
Latest data suggests 26 work at NeuroMetrix. When does the fiscal year end for NeuroMetrix?
NeuroMetrix's fiscal year ends in December. Where is NeuroMetrix based?
NeuroMetrix's address is: 4B Gill Street, Woburn, MA, United States, 01801 What is NeuroMetrix's ISIN number?
NeuroMetrix's international securities identification number is: US6412558073 What is NeuroMetrix's CUSIP number?
NeuroMetrix's Committee on Uniform Securities Identification Procedures number is: 641255203
More resources on Finder
More guides on Finder
-
How to buy Merck-and-Company stock (MRK)
Steps to owning and managing MRK, with 24-hour and historical pricing before you buy.
-
How to buy Eli Lilly and Company stock (LLY)
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
-
How to buy Intuitive Surgical stock (ISRG)
Steps to owning and managing ISRG, with 24-hour and historical pricing before you buy.
-
How to buy Vertex Pharmaceuticals stock (VRTX)
Steps to owning and managing VRTX, with 24-hour and historical pricing before you buy.
-
How to buy McKesson Corporation stock (MCK)
Steps to owning and managing MCK, with 24-hour and historical pricing before you buy.
-
How to buy UnitedHealth Group Incorporated stock (UNH)
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
-
How to buy Amgen stock (AMGN)
Steps to owning and managing AMGN, with 24-hour and historical pricing before you buy.
-
How to buy Abbott Laboratories stock (ABT)
Steps to owning and managing ABT, with 24-hour and historical pricing before you buy.
-
How to buy Pfizer stock (PFE)
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
-
How to buy Johnson & Johnson stock (JNJ)
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.
Ask a question